Publication

Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.

Journal Paper/Review - Jun 3, 2024

Units
PubMed
Doi
Contact

Citation
Bellomo J, Zeitlberger A, Padevit L, Stumpo V, Gönel M, Fierstra J, Nierobisch N, Reimann R, Witzel I, Weller M, Le Rhun E, Bozinov O, Regli L, Neidert M, Serra C, Voglis S. Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis. J Neurooncol 2024; 169:379-390.
Type
Journal Paper/Review (English)
Journal
J Neurooncol 2024; 169
Publication Date
Jun 3, 2024
Issn Electronic
1573-7373
Pages
379-390
Brief description/objective

Advancements in metastatic breast cancer (BC) treatment have enhanced overall survival (OS), leading to increased rates of brain metastases (BM). This study analyzes the association between microsurgical tumor reduction and OS in patients with BCBM, considering tumor molecular subtypes and perioperative treatment approaches.